Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

Clinical treatment of bladder cancer: An addition to Affibody-mediated tumor targeting

Reference number
Coordinator Haldex Holding AB - Haldex Holding AB
Funding from Vinnova SEK 542 000
Project duration September 2006 - December 2007
Status Completed

Last updated 25 November 2019

Reference number 2006-01797

Page statistics